67.00€
0.00€ (0.00%)
End-of-day quote: 05/10/2024
XTRA:MOR
MorphoSys Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | SWX | Hold | CHF92.32 | CHF105.00 | 0.00% | 9 | CHF188.37B |
| ROG | Roche Holding | SWX | Hold | CHF225.10 | CHF307.83 | 0.00% | 9 | CHF181.77B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.94 | $58.15 | 0.00% | 10 | $91.10B |
| ARGX | argenx | ENXTBR | Outperform | 347.90€ | 531.81€ | 0.00% | 10 | 20.66€B |
| INCY | Incyte | NasdaqGS | Outperform | $53.06 | $77.05 | 0.00% | 8 | $12.01B |
| REC | Recordati Industria Chimica e ... | BIT | Hold | 50.80€ | 48.61€ | 0.00% | 1 | 10.36€B |
| ZEAL | Zealand Pharma A/S | CPSE | Outperform | kr657.50 | kr357.00 | 0.00% | 2 | kr40.95B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.94 | £28.11 | 0.00% | 9 | £4.42B |
| ORNBV | Orion Oyj | HLSE | Hold | 37.68€ | 42.52€ | 0.00% | 3 | 5.12€B |
| ALK B | ALK-Abelló A/S | CPSE | Outperform | kr153.30 | kr109.25 | 0.00% | 3 | kr33.91B |
| INDV | Indivior PLC | LSE | Buy | £14.32 | £28.89 | 0.00% | 4 | £1.95B |
| ALM | Almirall | BME | Outperform | 9.16€ | 11.39€ | 0.00% | 3 | 1.79€B |
| XNCR | Xencor | NasdaqGM | Outperform | $22.48 | $37.91 | 0.00% | 4 | $1.50B |
| COPN | Cosmo Pharmaceuticals N.V. | SWX | Buy | CHF70.80 | CHF76.55 | 0.00% | 0 | CHF1.14B |
| FAE | Faes Farma | BME | Hold | 3.53€ | 3.90€ | 0.00% | 0 | 1.09€B |
| PHM | Pharma Mar | BME | Outperform | 33.30€ | 50.20€ | 0.00% | 1 | 536.95€M |
| BSLN | Basilea Pharmaceutica | SWX | Outperform | CHF42.95 | CHF65.63 | 0.00% | 0 | CHF474.13M |
| DBV | DBV Technologies | ENXTPA | Outperform | 1.21€ | 4.07€ | 0.00% | 1 | 115.65€M |
| MOLN | Molecular Partners | SWX | Outperform | CHF3.24 | CHF9.50 | 0.00% | 1 | CHF110.77M |
| KPTI | Karyopharm Therapeutics | NasdaqGS | Outperform | $1.09 | $6.00 | 0.00% | 1 | $118.80M |
